Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Top 50 Companies 2017: Notes & Methodology

For this annual special report, which is in its 31st year of publication, Med Ad News editors rank and profile the world’s top 50 companies that generate revenue from healthcare products.

Read More »

2017 Annual Report: Top 50 Companies – The Corner Turned

For the pharmaceutical industry, 2016 brought new blockbusters onto the market to ease the pain of patent expirations.

Read More »

AbbVie 2017: Humira, And What’s Next

While the world’s leading prescription drug Humira still accounts for the majority of AbbVie’s revenue, plenty else is bubbling up at the almost-five-year-old company.

Read More »

Amgen 2017: New Business Cycle

Amgen is featuring an unprecedented collection of new product offerings, including the first-ever biosimilar cancer treatment to receive U.S. marketing clearance.

Read More »

AstraZeneca 2017: Eyes To The Future

Although patent expirations continue to depress revenue, AstraZeneca executives believe in the pipeline.

Read More »

Bayer 2017: Monsanto & Oncology

For Bayer, the acquisition of Monsanto is intended to build its Crop Science division; meanwhile two significant approvals and two new hires enhance progress in oncology.

Read More »

Bristol-Myers Squibb 2017: Opdivo Steps Up

After years of hope and hype, Bristol-Myers Squibb’s centerpiece immuno-oncologic Opdivo is delivering the dollars.

Read More »

Gilead 2017: We Got Next

With sales of Harvoni and Sovaldi falling off, Gilead welcomed two new blockbusters to the company’s portfolio in 2016.

Read More »

GlaxoSmithKline 2017: New Business Priorities

Management set out a series of new priorities to 2020 to improve innovation, performance and trust in GlaxoSmithKline.

Read More »

Johnson & Johnson 2017: Transformational Innovation And Growth

With proven worldwide commercial capabilities and a robust product pipeline, Johnson & Johnson is firmly positioned to continue generating strong, long-term, sustainable growth.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!


Ad Right Bottom